Viking Therapeutics (VKTX) Reports In-Line Q2 EPS
Go back to Viking Therapeutics (VKTX) Reports In-Line Q2 EPS| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 32.94 -1.08 (3.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.02 | 52 Week High | $5.17 | |||
| Open | $33.86 | 52 Week Low | $0.94 | |||
| Day High | $33.97 | P/E | N/A | |||
| Day Low | $32.53 | EPS | $0.00 | |||
| Volume | 3,706,686 | |||||
